Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECIGEN, INC.PGEN · Entity 4356 | Director | March 09, 2023 | March 13, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECIGEN, INC.
Report date March 09, 2023 · Filed March 13, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 329,656 |
Reported balance
After 2023-03-09 transaction · row 1
1 source rowRow 1 · 2023-03-09 · Grant · Acquired 26,923 · Balance 329,656 F1: The shares were issued to the reporting person in lieu of an annual retainer of $31,500. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 53,418 |
Reported balance
After 2023-03-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-09 · Grant · Acquired 53,418 · Balance 53,418 F3: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. F4: The RSUs vest in full on March 9, 2024. |
| Option to Purchase Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.17 · Expires 2033-03-09 | Direct | 130,398 |
Reported balance
After 2023-03-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-03-09 · Grant · Acquired 130,398 · Balance 130,398 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 82,966 |
Reported balance
Holding disclosure · report date 2023-03-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 82,966 F2: Shares held in the Robert B. Shapiro Revocable Trust |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were issued to the reporting person in lieu of an annual retainer of $31,500.
F2: Shares held in the Robert B. Shapiro Revocable Trust
F3: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock.
F4: The RSUs vest in full on March 9, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2023 Filed Mar 13, 2023 17:10 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 130,398 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0000950103-23-004012 · dp190525_4-shapiro.xml · derivative · entry 4 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,398 Underlying: Common Stock · 130,398 shares Expires 2033-03-09 Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 17:10 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 53,418 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-004012 · dp190525_4-shapiro.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,418 Underlying: Common Stock · 53,418 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. F4 · derivative.exercise_date: The RSUs vest in full on March 9, 2024. F4 · derivative.expiration_date: The RSUs vest in full on March 9, 2024. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 17:10 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantCommon Stock | 26,923 | $1.17 | $31,499.91 |
DisclosureSEC source: 0000950103-23-004012 · dp190525_4-shapiro.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,656 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $31,500. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 20:06 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 61,576 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-23-003026 · dp189558_4-shapiro.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,576 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vested in full on February 22, 2023. F3 · derivative.expiration_date: The RSUs vested in full on February 22, 2023. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 20:06 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 61,576 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-23-003026 · dp189558_4-shapiro.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 17:09 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 16,212 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-22-005411 · dp170039_4-shapiro.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,212 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F3 · derivative.exercise_date: The RSUs vested in full on March 25, 2022. F3 · derivative.expiration_date: The RSUs vested in full on March 25, 2022. Read SEC document |
| March 25, 2022 Filed Mar 29, 2022 17:09 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 16,212 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-22-005411 · dp170039_4-shapiro.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 17:41 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 83,189 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000950103-22-003217 · dp167779_4-shapiro.xml · derivative · entry 4 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,189 Underlying: Common Stock · 83,189 shares Expires 2032-02-22 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 17:41 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 61,576 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-22-003217 · dp167779_4-shapiro.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,576 Underlying: Common Stock · 61,576 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. F4 · derivative.exercise_date: The RSUs vest in full on February 22, 2023. F4 · derivative.expiration_date: The RSUs vest in full on February 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 17:41 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantCommon Stock | 31,034 | $2.03 | $62,999.02 |
DisclosureSEC source: 0000950103-22-003217 · dp167779_4-shapiro.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,945 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $63,000. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 19:49 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 22,107 | $0.00 Strike: $7.71 | $0.00 |
DisclosureSEC source: 0001123292-21-000568 · edgar.xml · derivative · entry 4 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,107 Underlying: Common Stock · 22,107 shares Expires 2031-03-25 Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 19:49 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 16,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000568 · edgar.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,212 Underlying: Common Stock · 16,212 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Precigen, Inc. common stock. F4 · derivative.exercise_date: The restricted stock units vest in full on March 25, 2022. F4 · derivative.expiration_date: The restricted stock units vest in full on March 25, 2022. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 19:49 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantCommon Stock | 8,171 | $7.71 | $62,998.41 |
DisclosureSEC source: 0001123292-21-000568 · edgar.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,911 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $63,000. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 16:32 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 62,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-21-000484 · edgar.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,189 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. F3 · derivative.exercise_date: The RSUs vested in full on March 13, 2021. F3 · derivative.expiration_date: The RSUs vested in full on March 13, 2021. Read SEC document |
| March 13, 2021 Filed Mar 16, 2021 16:32 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 62,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-000484 · edgar.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen, Inc. common stock. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 18:34 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 96,324 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001123292-20-000571 · edgar.xml · derivative · entry 4 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,324 Underlying: Common Stock · 96,324 shares Expires 2030-03-13 Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 18:34 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantRestricted Stock Units · Derivative | 62,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-20-000571 · edgar.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,189 Underlying: Common Stock · 62,189 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Precigen, Inc. common stock. F4 · derivative.exercise_date: The restricted stock units vest in full on March 13, 2021. F4 · derivative.expiration_date: The restricted stock units vest in full on March 13, 2021. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 18:34 UTC | PRECIGEN, INC. PGEN · Entity 4356 | GrantCommon Stock | 31,343 | $2.01 | $62,999.43 |
DisclosureSEC source: 0001123292-20-000571 · edgar.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,551 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $63,000. Read SEC document |
| March 08, 2020 Filed Mar 10, 2020 16:14 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 24,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-20-000534 · edgar.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vested in full on March 8, 2020. F3 · derivative.expiration_date: The restricted stock units vested in full on March 8, 2020. Read SEC document |
| March 08, 2020 Filed Mar 10, 2020 16:14 UTC | PRECIGEN, INC. PGEN · Entity 4356 | Exercise / conversionCommon Stock | 24,703 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-20-000534 · edgar.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. Read SEC document |
| March 23, 2019 Filed Mar 26, 2019 17:51 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 7,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000577 · edgar.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,911 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vested in full on March 23, 2019. F3 · derivative.expiration_date: The restricted stock units vested in full on March 23, 2019. Read SEC document |
| March 23, 2019 Filed Mar 26, 2019 17:51 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionCommon Stock | 7,911 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000577 · edgar.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 19:12 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 42,450 | $0.00 Strike: $5.06 | $0.00 |
DisclosureSEC source: 0001123292-19-000470 · edgar.xml · derivative · entry 4 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,450 Underlying: Common Stock · 42,450 shares Expires 2029-03-08 Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 19:12 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantRestricted Stock Units · Derivative | 24,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000470 · edgar.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,614 Underlying: Common Stock · 24,703 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F4 · derivative.exercise_date: The restricted stock units vest in full one year from the grant date. F4 · derivative.expiration_date: The restricted stock units vest in full one year from the grant date. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 19:12 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantCommon Stock | 12,450 | $5.06 | $62,997.00 |
DisclosureSEC source: 0001123292-19-000470 · edgar.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,594 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $63,000. Read SEC document |
| March 23, 2018 Filed Mar 29, 2018 17:54 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 14,246 | $0.00 Strike: $15.80 | $0.00 |
DisclosureSEC source: 0001123292-18-000593 · edgar.xml · derivative · entry 4 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,246 Underlying: Common Stock · 14,246 shares Expires 2028-03-23 Read SEC document |
| March 23, 2018 Filed Mar 29, 2018 17:54 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantRestricted Stock Units · Derivative | 7,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-18-000593 · edgar.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,911 Underlying: Common Stock · 7,911 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock F4 · derivative.exercise_date: The restricted stock units vest in full one year from the grant date. F4 · derivative.expiration_date: The restricted stock units vest in full one year from the grant date. Read SEC document |
| March 23, 2018 Filed Mar 29, 2018 17:54 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantCommon Stock | 3,987 | $15.80 | $62,994.60 |
DisclosureSEC source: 0001123292-18-000593 · edgar.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,144 F1 · price: The shares were issued to the reporting person in lieu of an annual retainer of $63,000. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 16:34 UTC | PRECIGEN, INC. XON · Entity 4356 | PurchaseCommon Stock | 2,850 | $17.50 | $49,882.98 |
DisclosureSEC source: 0001225385-17-000105 · edgar.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 82,966 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.48 to $17.57, inclusive. The reporting person undertakes to provide to Intrexon Corporation ("Intrexon"), any security holder of Intrexon, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held in the Robert B. Shapiro Revocable Trust. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 16:26 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantOption to Purchase Common Stock (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $21.38 | $0.00 |
DisclosureSEC source: 0001225385-17-000054 · edgar.xml · derivative · entry 3 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-03-16 Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 16:26 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantCommon Stock | 3,274 | $0.00 | $0.00 |
DisclosureSEC source: 0001225385-17-000054 · edgar.xml · nonDerivative · entry 1 SHAPIRO ROBERT B · CIK 0001083227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,157 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.